Parent ratings of executive functioning in pediatric survivors of medulloblastoma and pilocytic astrocytoma.

Autor: Holland AA; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Department of Psychiatry, Children's Medical Center Dallas, Dallas, Texas, USA., Shamji JF; Department of Psychiatry, Children's Medical Center Dallas, Dallas, Texas, USA.; University of North Texas, Denton, Texas, USA., Clem MA; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Private practice in Dallas, Texas, USA., Perez R; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Private practice in Mission Viejo, California, USA., Palka JM; Department of Psychiatry, Children's Medical Center Dallas, Dallas, Texas, USA., Stavinoha PL; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Department of Psychiatry, Children's Medical Center Dallas, Dallas, Texas, USA.; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jazyk: angličtina
Zdroj: Applied neuropsychology. Child [Appl Neuropsychol Child] 2024 Jan-Mar; Vol. 13 (1), pp. 52-61. Date of Electronic Publication: 2022 Sep 16.
DOI: 10.1080/21622965.2022.2123707
Abstrakt: The present study compared parent-rated executive functioning in pediatric medulloblastoma (MB) and pilocytic astrocytoma (PA) survivors. Although standard care for both includes surgical resection, children with MB additionally receive chemotherapy and craniospinal irradiation. Given well-documented neurocognitive late effects associated with the latter, we anticipated poor parent-reported executive functioning in MB survivors. Parents/guardians of 36 MB survivors and 20 PA survivors completed the Behavior Rating Inventory of Executive Functioning (BRIEF). PA survivors were younger at diagnosis ( t [51.97] = 3.07, p < .001, d  = 0.86) and demonstrated higher IQ ( t [54] = -3.51, p < .001, d  = 0.95). However, relative to the MB group, the PA group was rated as having significantly more problems on all BRIEF scales (all p ≤ .05; d  = 0.30 - 1.10), except the Shift scale. Additionally, all mean BRIEF scores for MB survivors were within normal limits, whereas for PA survivors, all mean BRIEF scores except for Organization of Materials were significantly discrepant from normative means. Overall, PA survivors were rated as demonstrating poorer executive function than MB survivors. Five theories are discussed as possible explanations for these surprising findings: two related to group differences, two related to potential sources of parental bias, and one related to the nature of questionnaire-based assessment. All these theories represent directions for future research. Parent questionnaires such as the BRIEF may have real-world implications for pediatric brain tumor survivors. Future research should explore factors affecting parent ratings of executive functioning in these populations, along with comparison to performance-based measures.
Databáze: MEDLINE